Tag: Pain & Anaesthesia
PharmaSignal — Pain & Anaesthesia
AbbVie enters world of pain in up to $715M deal with China’s Haisco
April 13, 2026
BioSpace
The licensing deal marks AbbVie’s first foray into new pain medicines, a space where Vertex currently enjoys a lead thanks to the NaV1.8 inhibitor Journavx.
AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid
April 13, 2026
Pharmaceutical Technology
AbbVie’s deal with Haisco comes as many pharma companies look to restock their pipelines amid looming global patent expiries.